Core Laboratories (NYSE: CLB ) reported earnings on July 17. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Core Laboratories missed slightly on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share increased. GAAP earnings per share grew significantly.
Margins increased across the board.
Core Laboratories reported revenue of $263.1 million. The 11 analysts polled by S&P Capital IQ wanted to see net sales of $267.3 million on the same basis. GAAP reported sales were 6.5% higher than the prior-year quarter's $247.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.32. The 14 earnings estimates compiled by S&P Capital IQ predicted $1.32 per share. Non-GAAP EPS of $1.32 for Q2 were 14% higher than the prior-year quarter's $1.16 per share. GAAP EPS of $1.29 for Q2 were 16% higher than the prior-year quarter's $1.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 37.9%, 120 basis points better than the prior-year quarter. Operating margin was 31.1%, 70 basis points better than the prior-year quarter. Net margin was 22.7%, 130 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $270.6 million. On the bottom line, the average EPS estimate is $1.34.
Next year's average estimate for revenue is $1.08 billion. The average EPS estimate is $5.26.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 658 members out of 671 rating the stock outperform, and 13 members rating it underperform. Among 148 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 148 give Core Laboratories a green thumbs-up, and give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Core Laboratories is hold, with an average price target of $138.80.
Is Core Laboratories the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Core Laboratories to My Watchlist.